FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0104 Expires: January 31, 2005 Estimated average burden hours per response... 0.5

(Print or Type Responses)

1. Name and Address of Reporting Person *   Linden Robert V 2. Date of Event Requiring Statement (Month/Day/Year) 04/25/2008 3. Issuer Name and Ticker or Trading Symbol LEMAITRE VASCULAR INC [LMAT] (Last) (First) (Middle) C/O LEMAITRE VASCULAR, INC., 63 SECOND AVENUE 4. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director _____ 10% Owner __X__ Officer (give title below) _____ Other (specify below) VP, North American Sales 5. If Amendment, Date Original Filed(Month/Day/Year) (Street) BURLINGTON, MA 01803 6. Individual or Joint/Group Filing(Check Applicable Line) _X_ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person (City) (State) (Zip) Table I - Non-Derivative Securities Beneficially Owned

1.Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5) Common Stock 469 D   Common Stock 1,000 (1) D   Common Stock 2,300 (2) D   Common Stock 491 (3) D Â

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.			SEC 1473 (7-02)
	Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	09/06/2002(4)	09/05/2012	Common Stock	2,000	$ 7.44	D	Â
Stock Option (Right to Buy)	02/27/2004(4)	02/26/2014	Common Stock	1,250	$ 8.73	D	Â
Stock Option (Right to Buy)	01/27/2005(4)	01/26/2015	Common Stock	1,000	$ 10.45	D	Â
Stock Option (Right to Buy)	07/20/2005(4)	07/19/2015	Common Stock	1,770	$ 11.3	D	Â
Stock Option (Right to Buy)	12/22/2005(4)	12/21/2015	Common Stock	2,000	$ 11.78	D	Â
Stock Option (Right to Buy)	01/26/2006(4)	01/25/2013	Common Stock	500	$ 11.84	D	Â

Reporting Owners

Reporting Owner Name / Address	Relationships
	Director	10% Owner	Officer	Other
Linden Robert V C/O LEMAITRE VASCULAR, INC. 63 SECOND AVENUE BURLINGTON, MA 01803	Â	Â	  VP, North American Sales	Â

Signatures

/s/ Christopher H. Martin Attorney-in-Fact		04/29/2008
**Signature of Reporting Person		Date

Explanation of Responses:

*	If the form is filed by more than one reporting person, see Instruction 5(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1)	These shares represent the remaining unvested balance of restricted stock units issued on December 22, 2006, pursuant to a restricted stock unit agreement between LeMaitre Vascular, Inc. and Robert V. Linden. The 1,500 restricted stock units originally issued vest over a three-year period at a rate of one-third on the anniversary of the issuance date, with the balance vesting in equal annual installments over the remaining two years. In order to satisfy tax withholding obligations incurred upon the vesting of the first third of these restricted stock units on December 22, 2007, 148 of the 500 shares vesting on that date were withheld by the issuer.
(2)	These shares represent restricted stock units issued on May 2, 2007, pursuant to a restricted stock unit agreement between LeMaitre Vascular, Inc. and Robert V. Linden. The restricted stock units vest over a five-year period at a rate of 20% on the anniversary of the issuance date, with the balance vesting in equal annual installments over the remaining four years.
(3)	These shares represent restricted stock units issued on July 18, 2007, pursuant to a restricted stock unit agreement between LeMaitre Vascular, Inc. and Robert V. Linden. The restricted stock units vest over a five-year period at a rate of 20% on the anniversary of the issuance date, with the balance vesting in equal annual installments over the remaining four years.
(4)	This stock option is exercisable and vests over a five-year period at a rate of 20% on the anniversary of the date listed in the table, with the balance vesting in equal annual installments over the remaining four years.
  Remarks: Exhibit Index Exhibit 24 - Power of Attorney

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.